276 related articles for article (PubMed ID: 28867166)
1. Targeting Inflammation to Improve Tumor Drug Delivery.
Gkretsi V; Zacharia LC; Stylianopoulos T
Trends Cancer; 2017 Sep; 3(9):621-630. PubMed ID: 28867166
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Cancer: In Medio Stat Nano.
Molinaro R; Corbo C; Livingston M; Evangelopoulos M; Parodi A; Boada C; Agostini M; Tasciotti E
Curr Med Chem; 2018; 25(34):4208-4223. PubMed ID: 28933296
[TBL] [Abstract][Full Text] [Related]
3. Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy.
Cheng L; Liu W; Zhong C; Ni P; Ni S; Wang Q; Zhang Q; Zhang J; Liu J; Xu M; Yao X; Cen X; Wang G; Jiang C; Zhou F
J Ethnopharmacol; 2021 Apr; 270():113770. PubMed ID: 33388426
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory Drugs as Anticancer Agents.
Zappavigna S; Cossu AM; Grimaldi A; Bocchetti M; Ferraro GA; Nicoletti GF; Filosa R; Caraglia M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283655
[TBL] [Abstract][Full Text] [Related]
5. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
Majidpoor J; Mortezaee K
Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
[TBL] [Abstract][Full Text] [Related]
7. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
[TBL] [Abstract][Full Text] [Related]
8. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
9. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
10. Strategies of targeting pathological stroma for enhanced antitumor therapies.
Zhu Y; Yu F; Tan Y; Yuan H; Hu F
Pharmacol Res; 2019 Oct; 148():104401. PubMed ID: 31422113
[TBL] [Abstract][Full Text] [Related]
11. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy: a double-edged sword in cancer treatment.
Behranvand N; Nasri F; Zolfaghari Emameh R; Khani P; Hosseini A; Garssen J; Falak R
Cancer Immunol Immunother; 2022 Mar; 71(3):507-526. PubMed ID: 34355266
[TBL] [Abstract][Full Text] [Related]
13. Emerging strategies against tumor-associated fibroblast for improved the penetration of nanoparticle into desmoplastic tumor.
Yunna C; Mengru H; Fengling W; Lei W; Weidong C
Eur J Pharm Biopharm; 2021 Aug; 165():75-83. PubMed ID: 33991610
[TBL] [Abstract][Full Text] [Related]
14. Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound.
Ho YJ; Chu SW; Liao EC; Fan CH; Chan HL; Wei KC; Yeh CK
Theranostics; 2019; 9(24):7370-7383. PubMed ID: 31695774
[TBL] [Abstract][Full Text] [Related]
15. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.
Fukumura D; Jain RK
Microvasc Res; 2007; 74(2-3):72-84. PubMed ID: 17560615
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor.
Shen R; Peng L; Zhou W; Wang D; Jiang Q; Ji J; Hu F; Yuan H
J Control Release; 2022 Sep; 349():550-564. PubMed ID: 35841997
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
19. Smart Nanotherapeutic Targeting of Tumor Vasculature.
Li Z; Di C; Li S; Yang X; Nie G
Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
[TBL] [Abstract][Full Text] [Related]
20. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.
Papageorgis P; Polydorou C; Mpekris F; Voutouri C; Agathokleous E; Kapnissi-Christodoulou CP; Stylianopoulos T
Sci Rep; 2017 Apr; 7():46140. PubMed ID: 28393881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
